Nagwa Mohamed Ammar

Nagwa Mohamed Ammar

Auto-generated profile, based on publicly available information

Nagwa Mohamed Ammar

Department of Pharmacognosy, National Research Centre, Cairo 12622, Egypt

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Tetrahedron Letters
Verified
Journal Article
Closed access
AAAhmed H. Afifi
Ahmed H. Afifi
AEAhmed Hassan El-Desoky
Ahmed Hassan El-Desoky
HKHikaru Kato
Hikaru Kato
RMRemy E.P. Mangindaan
Remy E.P. Mangindaan
NVNicole J. de Voogd
Nicole J. de Voogd
STSachiko Tsukamoto
Sachiko Tsukamoto

16 June 2017 in Journal of Natural Products
Verified
Journal Article
Closed access
AAAhmed H. Afifi
Ahmed H. Afifi
IKIppei Kagiyama
Ippei Kagiyama
AEAhmed Hassan El-Desoky
Ahmed Hassan El-Desoky
HKHikaru Kato
Hikaru Kato
RMRemy E. P. Mangindaan
Remy E. P. Mangindaan
STSachiko Tsukamoto
Sachiko Tsukamoto

12 September 2013 in Drug Delivery
Verified
Journal Article
Closed access
PDF file
DMDina M. Mostafa
Dina M. Mostafa
NANagwa M. Ammar
Nagwa M. Ammar
SESameh H. Abd El-Alim
Sameh H. Abd El-Alim
AEAmira A. El-Anssary
Amira A. El-Anssary
The purpose of the present study is to formulate Glycyrrhiza glabra root and rhizome aqueous ethanolic extract in microemulsion carrier systems intended for transdermal delivery of incorporated antioxidant actives, flavonoids and polyphenols. The results obtained reveal that the microemulsion system ME3 possesses optimum properties regarding drug content (flavonoids and polyphenols), viscosity, pH, particle size and polydispersity index, zeta potential, stability, permeation of actives and hence possesses high in vitro and ex vivo antioxidant efficacy. These results indicate also that this microemulsion shows approximately 13-fold higher ex vivo antioxidant capacity compared with the liquorice extract solution. In addition, the proposed microemulsion is simple to dispense, cost effective and provides high patient compliance and convenience because of simple topical application and avoidance of non-comfortable oral or parenteral administration.

1 January 2006 in Natural Product Research
Verified
Journal Article
Closed access
NEN. H. El-Sayed
N. H. El-Sayed
NAN. M. Ammar
N. M. Ammar
SAS. Y. Al-Okbi
S. Y. Al-Okbi
LEL. T. Abou El-Kassem
L. T. Abou El-Kassem
TMT. J. Mabry
T. J. Mabry
Two new flavonoids, 8-hydroxyisoscoparin (1) and luteolin 7-O-glucoside 4″-sulfate (2), along with eight known flavonoids, including luteolin 7-O-glucoside 2″-sulfate, were isolated and identified from Washingtonia filifera. All compounds were characterized by 1H-NMR, 13C-NMR, CI-MS, FABMS and UV. The antioxidant activities of various W. filifera extracts were determined.

27 March 2014 in Drug Delivery
Verified
Journal Article
Closed access
DMDina Mahmoud Mostafa
Dina Mahmoud Mostafa
NANagwa Mohammed Ammar
Nagwa Mohammed Ammar
MBMona Basha
Mona Basha
RHRehab Hussein
Rehab Hussein
SASally El Awdan
Sally El Awdan
GAGamal Awad
Gamal Awad
Boswellia species are trees (family: Bruseraceae) found in India, Northern Africa and the Middle East. This study aims at formulating low dose biologically active fraction from the oleogum resin of Boswellia carterii (BC) in transdermal (TD) microemulsions (MEs) to acquire promoted anti-inflammatory efficacy. The bioactive fraction of the oleogum resin of BC was tested for solubility in different components. The most efficient were selected for constructing phase diagrams for ME preparation. The bioactive fraction was assayed by high performance liquid chromatography for 3-acetyl-11-keto-β-boswellic acid (AKBA), at 210 nm. The bioactive fraction was incorporated in 6 MEs. ME systems were evaluated for drug content and optimized systems were tested for characterization, permeation, skin irritancy and in vivo evaluation of anti-inflammatory activity. Two systems were selected; ME1 and ME4 composed of Tween 80: PEG 400 at 1:1 and 2:1 ratio, with oil content 7.78 and 17.5%, respectively. The systems showed high encapsulation efficiency >83%, small droplet size <100 nm, and suitable pH for topical application. Permeation parameters for ME1 were higher compared to ME4. Both MEs were non irritant. ME1 showed significantly higher anti-inflammatory activity versus the standard TD anti-inflammatory piroxicam. Optimized TD BC MEs could be used as a safe, effective and long acting alternative to oral anti-inflammatories, providing higher and prolonged efficacy and better patient compliance.

11 January 2016 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
NAN. M. Ammar
N. M. Ammar
SES. S. El-Hawary
S. S. El-Hawary
Doha MohamedDoha Mohamed
Doha Mohamed
AHAli El Halawany
Ali El Halawany
AEA. A. El-Anssary
A. A. El-Anssary
AEA. H. El-Dosoky
A. H. El-Dosoky